CD2 Overview
Molecule Name
T-cell surface antigen CD2
Synonyms
CD2,SRBC,LFA-2,T11
Drug Development Progress
Drugs in Clinical Trials3
Approved Drugs0
Highest Development StagePhase 2 Clinical
Target Synonym
T11，T-Cell Surface Antigen CD2，LFA-2，CD2 Antigens，CD2，LFA-3 Receptor，CD2 Molecule，Rosette Receptor，SRBC，CD2 Antigen，CD2 Antigen (P50)， Sheep Red Blood Cell Receptor，T-Cell Surface Antigen T11/Leu-5，Lymphocyte-Function Antigen-2，Erythrocyte Receptor
CD2 Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Siplizumab | MEDI-507; TCD-601 | Phase 2 Clinical | Catholic University Of Louvain, Itb-Med Llc | Amyotrophic Lateral Sclerosis; Anemia, Sickle Cell; Cholangitis, Sclerosing; Diabetes Mellitus, Type 1; End Stage Liver Disease; Graft vs Host Disease; Hepatitis, Autoimmune; Hidradenitis Suppurativa; Kidney Diseases; Kidney Failure, Chronic; Leukemia; Liver Cirrhosis; Liver Diseases; Lymphoma; Lymphoma, Extranodal NK-T-Cell; Lymphoma, T-Cell; Multiple Myeloma; Myelodysplastic Syndromes; Neoplasms; Plaque psoriasis; Psoriasis; Rejection of renal transplantation; Rejection of liver transplantation; Renal Insufficiency | Details |
| SBT-11-5301 | SBT115301 | Phase 1 Clinical | Sonoma Biotherapeutics Inc | Autoimmune Diseases | Details |
| PIT-565 | PIT-565 | Phase 1 Clinical | Novartis Pharma Ag | Arthritis, Rheumatoid; Lupus Erythematosus, Systemic; Lymphoma, B-Cell; Neoplasms; Nephrosis; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Details |